Observational Study to Assess Natural History in Cockayne Syndrome Patients
Pharmacokinetics and Safety Study of Single and Multiple Oral Doses Prodarsan™ in Patients With Cockayne Syndrome
Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study
† Study has passed its completion date and status has not been verified in more than two years.